acut
respiratori
distress
syndrom
ard
sever
form
acut
lung
injuri
respons
variou
diseas
variabl
etiolog
includ
sarscov
infect
date
comprehens
studi
genom
physiopatholog
ard
sar
lack
primarili
due
difficulti
find
suitabl
materi
studi
diseas
process
tissu
level
instead
blood
sputa
swap
herebi
attempt
provid
studi
analyz
autopsi
lung
sampl
patient
die
sar
show
differ
degre
sever
pulmonari
involv
perform
realtim
quantit
pcr
analysi
gene
function
role
inflamm
coagul
fibrosi
apoptosi
key
gene
confirm
protein
express
level
immunohistochemistri
correl
degre
morpholog
sever
present
individu
sampl
analyz
signific
express
level
identifi
anpep
receptor
cov
well
inhibit
pathway
ifn
product
tcell
recruit
gene
unassoci
date
ardssar
includ
hladra
slpi
clc
result
propos
therapeut
target
gene
compound
anpep
inhibitor
slpi
dexamethason
ultim
studi
may
serv
model
futur
tissuebas
analys
fibroinflammatori
condit
affect
lung
sever
acut
respiratori
syndrom
sar
emerg
lifethreaten
diseas
caus
case
death
countri
http
wwwwhoint
new
coronaviru
sarscov
identifi
caus
pathogen
ksiazek
et
al
trig
fever
dri
cough
pulmonari
infiltr
lymphopenia
thrombocytopenia
mortal
rate
sporad
case
sarscov
infect
due
laboratori
exposur
report
global
outbreak
end
mechan
underli
sarscov
infect
clinic
manifest
remain
poorli
understood
high
lethal
sar
enorm
econom
social
impact
highlight
import
elucid
pathogenesi
sarscov
infect
acut
respiratori
distress
syndrom
ard
sever
form
acut
lung
injuri
mortal
rate
associ
sarscov
infect
character
pulmonari
oedema
accumul
inflammatori
cell
result
sever
hypoxia
ard
initi
activ
local
inflammatori
mediat
eventu
spill
gener
circul
result
system
inflammatori
respons
sir
bhatia
moochhala
consequ
sir
excess
cytokinemedi
system
leukocyt
activ
lead
multipl
organ
dysfunct
syndrom
mod
owe
develop
ard
sarscov
infect
patient
often
suffer
mod
thu
explain
high
mortal
therefor
crucial
elucid
key
inflammatori
mediat
ard
character
novel
therapeut
target
ultim
aim
stop
amelior
diseas
progress
due
eas
avail
studi
reghunathan
et
al
ng
et
al
appli
peripher
blood
throat
swab
sputum
sampl
studi
express
cytokin
profil
sarscov
infect
patient
howev
glass
et
al
report
sar
viral
rna
local
bronchial
bronchiolar
epithelium
ding
et
al
shown
highest
viral
load
found
lung
tissu
sarscov
infect
patient
therefor
attempt
util
formalinfix
paraffinembed
ffpe
tissu
sampl
sarscov
infect
patient
obtain
clinic
autopsi
examin
experiment
materi
allow
us
studi
molecular
chang
occur
tissu
level
achiev
larger
biolog
relev
onset
sarscov
epidem
hypothes
antivir
activ
respons
sarscov
infect
would
mediat
complex
mechan
cytokin
chemokin
macrophag
tcell
would
involv
variou
pathway
saltotellez
et
al
studi
character
inflammatori
mediat
involv
develop
ard
sarscov
infect
patient
investig
gene
express
profil
link
physiopatholog
chang
occur
lung
show
gene
significantli
upregul
gene
significantli
downregul
progress
diseas
gene
greatli
improv
knowledg
pathogenesi
sarscov
infect
contribut
toward
develop
therapeut
intervent
fatal
diseas
perhap
ard
whole
total
formalinfix
paraffinembed
ffpe
lung
tissu
seven
patient
die
sar
posit
pcr
obtain
health
scienc
author
singapor
approv
compet
institut
ethic
review
board
dsrb
refer
code
clinic
inform
patient
shown
tabl
two
ffpe
lung
sampl
case
normal
lung
histolog
includ
normal
control
case
caus
death
total
unrel
lung
patholog
directli
indirectli
macroscop
histolog
lung
diseas
lung
sampl
taken
section
specimen
stain
haematoxylin
eosin
h
e
examin
light
microscopi
fig
five
seven
patient
multipl
tissu
differ
area
lung
show
diseas
differ
grade
evolut
sampl
repres
spectrum
chang
ard
show
clear
diseas
progress
earli
stage
lead
endstag
lung
fibrosi
morpholog
descript
sampl
shown
tabl
sever
section
ffpe
sampl
collect
rnasefre
environ
rnasezap
ambion
inc
tx
use
rna
extract
thick
immunohistochemistri
experi
thick
total
rna
isol
section
ffpe
sampl
use
paraffin
block
rna
isol
kit
ambion
inc
tx
ffpe
section
incub
xylen
remov
paraffin
tissu
digest
proteinas
k
rna
isol
use
acid
phenol
chloroform
follow
precipit
isopropanol
use
linear
acrylamid
carrier
dnase
treatment
includ
elimin
contamin
genom
dna
rtpcr
g
rna
templat
perform
use
superscript
iii
tm
invitrogen
ca
allow
better
specif
higher
yield
fulllength
cdna
product
rnase
h
digest
later
introduc
remov
rna
templat
cdna
rna
hybrid
molecul
higher
sensit
design
low
densiti
taqman
array
ldta
micro
fluidic
card
appli
biosystem
ca
quantit
realtim
pcr
experi
carri
predevelop
taqman
probe
taqman
univers
pcr
master
mix
realtim
pcr
appli
biosystem
ca
system
realtim
pcr
experi
done
four
replic
reaction
realtim
pcr
result
express
fold
chang
mrna
express
patient
sampl
respect
control
sampl
result
normal
express
housekeep
gene
pcr
reaction
ihc
perform
accord
manufactur
instruct
briefli
ffpe
section
dewax
hydrat
microwav
block
endogen
peroxidas
slide
incub
antibodi
clone
dako
santa
cruz
clone
dako
stain
h
room
temperatur
follow
incub
envis
hrp
detect
reagent
dako
chemmat
normal
bone
marrow
section
use
posit
control
show
represent
inflammatori
cell
type
neg
control
prepar
replac
primari
antibodi
trisbuff
salin
express
individu
antibodi
tissu
section
semiquantit
score
pathologist
look
overal
express
morpholog
discern
cell
type
section
mannwhitney
sam
analysi
perform
identifi
gene
significantli
upor
downregul
progress
diseas
mannwhitney
analysi
pvalu
consid
signific
qvalu
consid
signific
sam
test
appli
ingenu
pathway
analysi
ingenu
system
inc
redwood
citi
ca
studi
function
network
canon
pathway
gene
mean
express
character
diseas
sever
sarscov
infect
individu
ffpe
lung
sampl
base
histopatholog
featur
describ
tabl
group
ffpe
sampl
earli
grade
late
grade
diseas
stage
demonstr
clear
diseas
progress
earli
stage
lead
endstag
lung
fibrosi
due
bacteri
overgrowth
observ
histolog
section
sampl
b
elimin
analysi
realtim
pcr
experi
carri
valid
express
level
gene
refer
supplementari
function
role
inflamm
coagul
fibrosi
apoptosi
refer
fig
group
sampl
earli
late
diseas
stage
comput
averag
express
level
individu
gene
identifi
list
gene
overexpress
tabl
mean
express
diseas
sampl
versu
control
sampl
refer
tabl
use
ingenu
pathway
analysi
studi
function
overexpress
gene
refer
supplementari
list
gene
statist
analysi
show
gene
significantli
p
overexpress
gene
significantli
p
suppress
refer
fig
tabl
progress
diseas
earli
versu
late
diseas
stage
summar
tabl
transcriptom
sarscov
infect
patient
late
diseas
stage
character
high
express
gene
code
chemokin
complement
compon
antibacteri
respons
protein
cytokin
receptor
apoptosisrel
cystein
proteas
immunoglobulin
receptor
famili
member
growth
factor
transcript
factor
major
histocompat
complex
antigen
hladra
receptor
anpep
proteas
hp
slpi
cell
adhes
molecul
gene
miscellan
function
bpi
contrast
notabl
low
express
level
cytokin
clc
cell
adhes
molecul
transcript
factor
proteas
gbp
found
patient
late
diseas
stage
use
ingenu
pathway
analysi
demonstr
list
overexpress
gene
involv
immunolog
respons
refer
fig
hand
gene
appear
involv
network
analysi
known
report
function
henc
highlight
novel
insight
studi
major
overexpress
gene
import
role
pathogenesi
sarscov
infect
still
remain
unreport
order
confirm
gene
express
profil
function
signific
perform
protein
express
analysi
ihc
pecam
select
differenti
express
diseas
group
b
directli
attribut
specif
cellular
type
macrophag
lymphocyt
endotheli
c
robust
report
protocol
use
routin
patholog
set
easili
visual
quantifi
result
demonstr
gene
express
profil
correl
well
degre
protein
express
refer
fig
highlight
reliabl
gene
express
profil
result
main
contribut
studi
establish
gene
major
biolog
possibl
clinic
import
complex
pathobiolog
reaction
sarscov
infect
result
ard
discuss
role
import
list
gene
upor
downregul
pathogenesi
ard
sarscov
infect
studi
bactericidalpermeabilityincreas
protein
bpi
appear
highest
express
gene
late
diseas
stage
major
constitu
neutrophil
antiinflammatori
properti
play
integr
part
innat
immun
elsbach
anoth
gene
significantli
overexpress
diseas
sampl
report
caus
airway
inflamm
play
role
neutrophil
activ
pathogenesi
bronchiol
also
shown
upregul
lung
sampl
sarscov
infect
macaqu
de
lang
et
al
report
aichel
et
al
show
bpi
releas
neutrophil
timedepend
manner
follow
bacteri
encount
cystic
fibrosi
patient
accord
studi
data
demonstr
upregul
bpi
sarscov
infect
presum
attempt
activ
immun
respons
combat
sarscov
infect
angiotensin
convert
enzym
identifi
function
cellular
receptor
sarcov
express
high
level
primari
target
cell
sarscov
li
et
al
suggest
overexpress
patient
sampl
might
correl
increas
suscept
sarscov
infect
tachykinin
precursor
present
sensori
nerv
lung
report
indic
contribut
pathophysiolog
bronchial
hyperrespons
airway
construct
inflamm
chronic
bronchiti
cough
springer
et
al
show
overexpress
contribut
toward
appear
abovement
symptom
sarscov
infect
patient
key
recognit
receptor
innat
immun
system
tolllik
receptor
tlr
requir
transmembran
receptor
eg
tlr
initi
stimulusspecif
activ
process
tlr
respons
quick
recognit
respons
pathogen
consequ
vital
role
surviv
boost
host
immun
system
lifethreaten
infect
oneil
provid
evid
innat
immun
respons
activ
sarscov
infect
interferon
regulatori
necessari
transcript
induct
ifnstimul
gene
isg
respons
viral
infect
tlr
signal
cheng
et
al
signific
upregul
respons
sarscov
infect
indic
distinct
contribut
innat
acquir
immun
via
induct
isg
alanyl
aminopeptidas
anpep
transmembran
proteas
present
leukocyt
identifi
cellular
receptor
human
coronaviru
vijgen
et
al
find
strongli
suggest
enrich
anpep
featur
late
diseas
stage
sarscov
infect
tumor
necrosi
factor
receptor
superfamili
member
key
signal
molecul
express
antigenpres
cell
immun
system
detect
upregul
sarscov
infect
may
activ
cell
induc
adhes
molecul
carcino
embryon
antigen
relat
cell
adhes
molecul
express
activ
monocyt
granulocyt
overcom
invad
microorgan
dere
et
al
also
upregul
studi
insulinlik
growth
report
induc
hypoxiainduc
activ
hypox
express
target
gene
involv
cell
adapt
low
oxygen
concentr
fukuda
et
al
macrophag
scaveng
receptor
one
hypoxiainduc
gene
involv
clearanc
pathogen
apoptot
cell
platt
et
al
haptoglobin
hp
produc
inflammatori
cell
protect
oxid
stress
inflamm
eaton
et
al
togeth
observ
upregul
hp
demonstr
role
adapt
cell
oxid
stress
hypox
environ
anoth
common
occurr
sarscov
infect
patient
secretori
leukocyt
proteinas
inhibitor
slpi
produc
lung
tissu
well
monocyt
alveolar
macrophag
neutrophil
ard
slpi
markedli
increas
bronchoalveolar
lavag
fluid
posit
correl
multipl
organ
failur
score
mof
sallenav
et
al
asano
et
al
report
increas
slpi
sarscov
infect
lung
consist
hypothesi
slpi
alarm
inhibitor
onset
inflammatori
process
calcium
bind
protein
present
extracellular
milleu
infect
inflammatori
process
shown
regul
monocyt
lymphocyt
neutrophil
migrat
frosch
et
al
studi
also
show
upregul
mediat
endocytosi
exocytosi
respons
concord
report
reghunathan
et
al
express
endosom
compart
cell
mononuclear
phagocyt
lineag
gene
upregulatoin
direct
express
monocyt
recruit
macrophag
differenti
confirm
protein
upregul
ihc
local
express
cytoplasm
compart
macrophag
upregul
fibroblast
growth
could
explain
involv
immun
system
modul
well
thrombin
accumul
fibrin
deposit
samoszuk
et
al
integrin
iib
serv
receptor
fibrinogen
upon
platelet
stimul
import
platelet
adhes
clot
retract
calzada
et
al
observ
signific
upregul
earli
stage
sarscov
infect
suggest
upon
sarscov
entri
stimul
mediat
platelet
aggreg
adhes
cardiotrophinlik
cytokin
clc
report
activ
prolifer
b
cell
antibodi
product
senaldi
et
al
observ
overexpress
clc
earli
stage
sarscov
infect
indic
may
import
phase
bcell
relat
immun
result
indic
earli
stage
sarscov
infect
also
induc
product
interferongammainduc
protein
potent
chemoattract
activ
cell
natur
killer
nk
cell
vanguri
farber
lead
leukocyt
activ
extravas
migrat
thu
gener
rapid
innat
antivir
respons
aid
attempt
viral
clearanc
sarscov
infect
lung
gtpase
guanylatebind
major
protein
antiprolif
role
endotheli
cell
upon
invas
inflammatori
cytokin
ic
express
inhibit
progress
sarscov
infect
thu
propos
repress
import
restor
necessari
neovascular
accompani
late
inflammatori
chang
sarscov
relat
ard
signal
transduc
activ
transcript
import
transmit
inflammatori
cytokin
signal
induc
inflammatoti
mediat
inflammatori
cell
phosphoryl
transloc
transcript
factor
nucleu
activ
ifninduc
gene
particip
host
defens
levi
darnel
suggest
downregul
increas
suscept
host
sarscov
infect
impair
ifn
respons
inflammatori
mediat
indic
studi
possibl
vitro
inhibitor
postul
gene
alreadi
natur
synthet
inhibitor
may
prove
use
start
point
futur
therapeut
design
priorit
avenu
therapeut
intervent
natur
synthet
inhibitor
anpep
bestatin
abl
influenc
immun
function
major
biolog
event
cell
prolifer
invas
angiogenesi
bauvoi
dauzonn
essenti
recruit
sarscov
neutrophil
macrophag
cell
phagocytosi
treatment
macrophag
popul
dexamethason
result
strong
increas
synthesi
secret
armbrust
et
al
thu
bestatin
dexamethason
could
use
therapeut
agent
combin
other
sarscov
infect
tac
receptor
antagonist
report
demonstr
signific
bronchoprotect
role
daoui
et
al
could
possibl
therapeut
target
sar
diseas
final
airway
inflamm
often
associ
infiltr
activ
neutrophil
subsequ
proteas
releas
prevent
effect
slpi
contain
excess
releas
proteas
specif
site
synthesi
lung
defin
function
make
slpi
attract
candid
potenti
therapeut
agent
gene
express
measur
take
place
damag
tissu
like
elucid
complet
physiopatholog
pictur
diseas
base
evid
gene
express
studi
hypothes
sarscov
infect
requir
express
anpep
receptor
cov
ii
impair
immun
system
inhibit
pathway
subsequ
iii
prevent
product
ifn
hypothes
model
sar
pathogenesi
new
novel
insight
fig
complex
immunolog
spectrum
chang
sarscov
relat
ard
would
involv
numer
biolog
event
relat
neutrophil
activ
detect
sarscov
specif
target
cell
migrat
thrombosi
vascular
prolifer
among
other
studi
character
main
gene
function
highlight
time
diseas
develop
biomark
import
due
limit
collect
lung
tissu
collect
deceas
patient
timepoint
manner
diseas
onset
manifest
sarscov
infect
unabl
conclud
express
profil
explain
exclus
effect
sarscov
effect
ongo
process
tissu
level
concomit
hypoxia
cell
infiltr
part
patholog
process
even
effect
therapeut
modal
use
conclus
studi
demonstr
initi
phase
sarscov
infect
antivir
cytokin
suppress
affect
lung
tissu
produc
abund
chemokin
inflammatori
cell
recruit
parallel
descript
describ
pathophysiolog
sarscov
relat
tissu
chang
hypothes
use
diseas
sever
marker
therapeut
target
